Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001698530-22-000022
Filing Date
2022-03-25
Accepted
2022-03-25 17:26:21
Documents
8
Effectiveness Date
2022-03-25

Document Format Files

Seq Description Document Type Size
1 S-8 exicure-formsx8march2022.htm S-8 61899
2 EX-FILING FEES ex107_s-8march2022.htm EX-FILING FEES 21997
3 EX-5.1 ex51_cooleyopinionfors-8maa.htm EX-5.1 11289
4 EX-23.1 ex231_kpmgconsentxforms-8m.htm EX-23.1 1958
5 image.jpg GRAPHIC 1931
6 image_0.jpg GRAPHIC 1225
7 image_1.jpg GRAPHIC 238
8 image_4.jpg GRAPHIC 173
  Complete submission text file 0001698530-22-000022.txt   103391
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263876 | Film No.: 22772585
SIC: 2834 Pharmaceutical Preparations